One specific example is using the inhibitor KH‐3 to disrupt the interaction of the RNA‐binding protein Hu antigen R (HuR) and FOXQ1 (Forkhead Box Q1) mRNA, leading to inhibition of breast cancer invasion in high‐grade tumors with poor clinical outcome (X. Wu et al., 2020). Here, FOXQ1 is linked to breast cancer.